AXIM Biotechnologies’ Development of Rapid Test for COVID-19 Neutralizing Antibodies is Cited to Demonstrate over 90% Sensitivity and 100% Specificity
November 09, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19...
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – RECAF, LGDOF
October 28, 2021 09:36 ET
|
The Rosen Law Firm PA
NEW YORK, Oct. 28, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
AXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19
October 12, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological,...
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
August 30, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting...
Biozek Medical Launches Non-Invasive Oral Fluid COVID-19 (Saliva) Antigen Rapid Test to Combat "Nasal Swab Fatigue" and Mutating Variants
August 04, 2021 17:22 ET
|
Biozek Medical
Apeldoorn, Netherlands, Aug. 04, 2021 (GLOBE NEWSWIRE) -- As businesses look for ways to remain safely open, Biozek Medical announced the launch of their new COVID-19 Antigen Saliva Rapid test, a...
Global Genetic Toxicology Testing Market is Estimated to Grow at a CAGR of 10.0% from 2021 to 2030
July 05, 2021 06:00 ET
|
Quince Market Insights
Pune, India, July 05, 2021 (GLOBE NEWSWIRE) -- The global genetic toxicology testing market is estimated to value at USD 1.90 billion in 2021 and is expected to grow at a CAGR of 10.0%. Market...
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO of XPhyto Therapeutics Corp.
June 17, 2021 09:00 ET
|
XPhyto Therapeutics Corp.
NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Global Biologics Safety Testing Market Size to Grow at a CAGR of 12.3% from 2021 to 2030
June 15, 2021 06:30 ET
|
Quince Market Insights
Pune, India, June 15, 2021 (GLOBE NEWSWIRE) -- The global biologics safety testing market has been estimated to reach USD 3.0 billion in 2021 and is projected to grow at a CAGR of 12.3% during the...
Nexen Tire ranks first in ACE Lenkrad summer tire test 2021
April 05, 2021 05:00 ET
|
Nexen Tire
SEOUL, South Korea, April 05, 2021 (GLOBE NEWSWIRE) -- Nexen Tire, a leading global tire manufacturer, today announced that the N'FERA Sport has earned first place in the summer tire test conducted...
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test
March 29, 2021 08:30 ET
|
XPhyto Therapeutics Corp.
VANCOUVER, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on...